James R Tobin sold $2.2M of GMED
director at GLOBUS MEDICAL INC. 30,000 shares at an average of $74.58, traded Sep 15, 2026, filed Sep 16, 2026.
Score components
- +15RoleDirector
- +25Trade size$2.2M at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-393147, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | MOption exercise Class A Common Stock | +15,000 | $53.75 | $806k | 15,000 | 25 d ago |
| Sep 15, 2026 | MOption exercise Class A Common Stock | +15,000 | $63.68 | $955k | 30,000 | 25 d ago |
| Sep 15, 2026 | SOpen-market sale Class A Common Stock | -30,000 | $74.58 | $2.2M | 0 | 25 d ago |
| Sep 15, 2026 | MOption exercise Stock Option (Right to Buy Class A Common Stock)derivative | -15,000 | $0.00 | $0 | 0 | 25 d ago |
| Sep 15, 2026 | MOption exercise Stock Option (Right to Buy Class A Common Stock)derivative | -15,000 | $0.00 | $0 | 0 | 25 d ago |
Related signals
Other insiders at GLOBUS MEDICAL INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 19Weak | GLOBUS MEDICAL INC | Ann D Rhoads director | $590k 7,500 shares | -17% | |
| 32Weak | GLOBUS MEDICAL INC | Keith W Pfeil COO, CFO | $1.3M 14,167 shares | -100% | |
| 27Weak | GLOBUS MEDICAL INC | Kelly Huller SVP, GC, Corporate Secretary | $218k 2,500 shares | -100% | |
| 35Weak | GLOBUS MEDICAL INC | David D Davidar director | $3.4M 40,000 shares | -7% | |
| 50Moderate | GLOBUS MEDICAL INC | Daniel T Scavilla President, CEO | $11M 130,000 shares | -100% | |
| 60Notable | GLOBUS MEDICAL INC | Dan Lemaitre director | $1.2M 14,375 shares | -108% | |
| 43Moderate | GLOBUS MEDICAL INC | Daniel T Scavilla President, CEO | $4.8M 60,000 shares | -100% | |
| 24Weak | GLOBUS MEDICAL INC | Kelly Huller SVP, GC, Corporate Secretary | $405k 5,000 shares | -100% | |
| 28Weak | GLOBUS MEDICAL INC | David D Davidar director | $3.8M 50,000 shares | -9% | |
| 7Weak | GLOBUS MEDICAL INC | Kelly Huller SVP, GC, Corporate Secretary | $563k 7,500 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.